Diosmetin ameliorates imiquimod-induced psoriasis by regulating apoptosis and inflammation via toll-like receptor 4/nuclear factor kappa B pathway

• Autors principals: Jinyan Yang (Autor), Mingfeng Zhan (Autor), Zhaohui Chen (Autor), Lihua Li (Autor), Juan Lu (Autor), Min Yang (Autor), Xuewen Gao (Autor)
• Format: Llibre
• Publicat: Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: Psoriasis is a common skin inflammatory disease. Dysregulated growth and differentiation of keratinocytes are the main characteristics of psoriasis. Diosmetin is a naturally occurring flavonoid with antioxidant, anti-inflammatory, and antibacterial properties. However, the anti-psoriatic...